Yunlong Richard Cao on X: It's critical to test how these RBD hotspots could combine to achieve max immune evasion without losing affinity to ACE2. After careful consideration, besides the emerging K478R/F456L

Frontiers The XBB.1.5 slightly increase the binding affinity for host receptor ACE2 and exhibit strongest immune escaping features: molecular modeling and free energy calculation

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity

IJMS, Free Full-Text

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Frontiers Nanobodies: COVID-19 and Future Perspectives

The Potential for SARS-CoV-2 to Evade Both Natural and Vaccine-induced Immunity

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants

Thread by @yunlong_cao on Thread Reader App – Thread Reader App